37
The
th Annual Meeting of March 19-20, 2016 The Endocrine Society and The Diabetes Association of the R.O.C. (Taiwan)
PL
Prof. André Lacroix, M.D. Personal Information Nationality: Canadian Professor, Department of Medicine, Division of Endocrinology CHUM Director, Laboratory of endocrine pathophysiology, CRCHUM Tour Viger, 900, rue Saint-Denis, Rm R08-474, Montréal (Québec) H2X 0A9 E-mail: andre.lacroix@umontreal.ca Pr. Lacroix completed M.D. degree in 1972 and specialization in endocrinology in 1977 at Université de Montréal. This was followed by Endocrine fellowship at Vanderbilt University in Nashville, TN from 1976-78 with Grant W Liddle, David N Orth, TJ McKenna, and at the National Institutes of Health in Bethesda, MD from 1978-80 with Marc E Lippman and during a sabbatical year of biotechnology in 1986 with MB Sporn and Anita Roberts. Since 1980, he has been Director of Endocrine Pathophysiology laboratory at Institut de Recherches Cliniques de Montréal (IRCM) until 1992 and now at the CHUM Research center (CRCHUM). He served as chief of Endocrine Division at Hôtel-Dieu hospital and as Director of the Endocrinology Training Program of Université de Montréal. He was Chairman of the Department of Medicine from 2002-2008 and Associate Director General for Medical and Academic Affairs at CHUM (2008-2012). He served as president of the Canadian Society of Endocrinology and Metabolism (2005-2007) and on the executive board of the International Society of Endocrinology (2010-16). He is currently co-editor of the Adrenal Section of UpToDate (Boston, MA), Senior Editor of the European Journal of Endocrinology, editorial board member of Journal of Clinical Endocrinology and Metabolism. He received the Medical Leadership award from CHUM Foundation in 1999 and the Robert Volpé 2010 award from CSEM in recognition for his contributions to Endocrinology in Canada. He was elected Fellow of the Canadian Academy of Health Sciences in 2008 (FCAHS). Major Areas of Research: Genetics and pathophysiology of adrenal tumors and hyperplasias leading to Cushing’s syndrome, primary aldosteronism and adrenal tumorigenesis. Role of aberrant adrenal hormone receptors in adrenal overfunction. New drugs in the therapy of Cushing’s disease and primary aldosteronism, of adrenocortical cancer and pheochromocytomas. He has published more than 180 articles or book chapters, 250 scientific meeting abstracts and was invited to give 250 conferences at national and international institutions or scientific meetings. Selected publications 1. Lacroix, A., Bolté, E., Tremblay, J., Dupré, J., Poitras, P., Fournier, H., Garon, J., Garrel, D., Bayard, F., Taillefer, R., Flanagan, R., and Hamet, P. Gastric inhibitory polypeptide-dependent cortisol hypersecretion - a new cause of Cushing’s syndrome. N. Engl. J. Med.; 327:974-980. 1992 (274citations) IF 47.05 2. Gagner, M., Lacroix, A., and Bolté, E. Laparoscopic approach to adrenalectomy in Cushing’s syndrome and pheochromocytoma. Letter to the Editor. N. Engl. J. Med.; 327:1033. 1992 (1361 citations) IF 47.05 38
